Catalyst Financial Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Sell
2,412
-1,473
-38% -$407K 0.05% 217
2026
Q1
$1.15M Buy
3,885
+1,990
+105% +$591K 0.14% 97
2025
Q4
$517K Buy
1,895
+107
+6% +$29.1K 0.06% 164
2025
Q3
$483K Buy
1,788
+10
+0.6% +$2.72K 0.06% 177
2025
Q2
$490K Buy
1,778
+66
+4% +$17.9K 0.05% 166
2025
Q1
$454K Buy
1,712
+59
+4% +$14.6K 0.08% 160
2024
Q4
$384K Buy
1,653
+19
+1% +$4.37K 0.07% 169
2024
Q3
$361K Sell
1,634
-105
-6% -$21.7K 0.07% 173
2024
Q2
$342K Buy
1,739
+23
+1% +$4.75K 0.08% 169
2024
Q1
$358K Buy
1,716
+30
+2% +$6.3K 0.09% 144
2023
Q4
$355K Sell
1,686
-136
-7% -$29K 0.1% 139
2023
Q3
$365K Buy
1,822
+283
+18% +$56.3K 0.12% 131
2023
Q2
$285K Sell
1,539
-125
-8% -$23.1K 0.1% 148
2023
Q1
$319K Buy
1,664
+329
+25% +$59.5K 0.14% 115
2022
Q4
$224K Buy
+1,335
New +$232K 0.12% 146

Other funds holding CME

Catalyst Financial Partners's CME Position: Q2 2026 in Review

Catalyst Financial Partners reduced its CME Group (CME) stake by 38% in Q2 2026, selling an estimated $407K and leaving 2,412 shares worth $533K. The position accounts for 0.05% of the portfolio, ranked #217.

Catalyst Financial Partners first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.15M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Catalyst Financial Partners held 2,412 shares of CME Group worth $533K as of Q2 2026.
  • Catalyst Financial Partners sold 1,473 CME Group shares in Q2 2026, an estimated $407K.
  • CME Group made up 0.05% of Catalyst Financial Partners's portfolio in Q2 2026, its #217 holding.
  • Catalyst Financial Partners first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Catalyst Financial Partners's CME Group position peaked at $1.15M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.